Many of the trials that we have supported have been phase IV studies or late phase clinical trial programs. These have ranged from small, single country marketing studies through to large global observational trials. In certain circumstances, we have also been able to support clinical monitoring in addition to the data and safety-related aspects of the trials.

We are able to advise on technologiesthat can be utilized and offer expertise when developing the trial and defining patient and visit numbers to ensure study relevance. Being able to pool these data with those generated in other studies throughout the product development can also help to make better use of the data for decision making processes. We understand there are often budget and resource constraints for certain types of late phase studies and our aim is to offer the best solution within the designated budget, whilst maintaining quality and maximizing outcomes.